NCT07037251

Brief Summary

The main purposes of the study are: To determine the prevalence of fibromyalgia among patients with suspected endometriosis during their initial visit to an endometriosis clinic. Secondary aims include staging of endometriosis in these patients according to the AAGL (16,17) endometriosis classification and correlate the prevalence of fibromyalgia with ultrasound and surgical findings. Another aim will be to assess the improvement in symptoms in patients diagnosed with both disorders in comparison to patients with either one separately. All women with suspected endometriosis will be asked to complete the questionnaire before their first visit to the doctor's office. Study design

  • A single center prospective cohort study
  • All patients attending to Endometriosis clinic at Assuta Ashdod University Hospital with suspected endometriosis at initial visit and who will consent and able to sign the consent form for participation.
  • Fibromyalgia will be defined by the ACR Preliminary Diagnostic Criteria, including Widespread Pain Index, Symptoms severity scale and somatic symptoms.
  • The treating physician will blinded to questionnaire results until the end of the visit.
  • At the end of the visit the questionnaire will be analyzed by one of the investigators and if fibromyalgia is found, the patient will also be referred for treatment of this disorder along with the endometriosis treatment.
  • Questionnaires will be coded with numbers from 1 to 150.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
10mo left

Started Jul 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Jul 2024May 2027

First Submitted

Initial submission to the registry

May 19, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
12 months until next milestone

First Posted

Study publicly available on registry

June 25, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

June 25, 2025

Status Verified

June 1, 2025

Enrollment Period

2.8 years

First QC Date

May 19, 2024

Last Update Submit

June 23, 2025

Conditions

Keywords

fibromialgiaendometriosis

Outcome Measures

Primary Outcomes (1)

  • Occurrence of Fibromyalgia in patients with endometriosis

    Occurrence of Fibromyalgia on first visit to endometriosis clinic

    within 2 years from the beginning of the study

Secondary Outcomes (2)

  • staging of endometriosis in these patients according to the AAGL (16,17) endometriosis classification and correlate the prevalence of fibromyalgia with ultrasound and surgical findings.

    The questionnaire will be annalized at the end of the study, within 2 years of initial visit

  • To determine the prevalence of fibromyalgia among patients with suspected endometriosis during their initial visit to an endometriosis clinic.

    questionnaire for fibromialgia will be filled up to one day from visit to clinic

Interventions

there is no intervention only observation

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility Detailswomen
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All women with suspected endometriosis in their first visit to endometriosis clinics in Assuta Ashdod Hospital

You may qualify if:

  • All women with suspected endometriosis in their first visit to endometriosis clinics in Assuta Ashdod Hospital

You may not qualify if:

  • Proven fibromyalgia prior to the first visit.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assuta Ashdod University Hospital

Ashdod, Israel

RECRUITING

MeSH Terms

Conditions

FibromyalgiaEndometriosis

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Central Study Contacts

Oshri Barel, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2024

First Posted

June 25, 2025

Study Start

July 1, 2024

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

June 25, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations